v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
REVENUES:        
Product revenue $ 3,363,692 $ 2,236,035 $ 5,956,855 $ 4,324,213
License and other revenue 35,709 35,709 71,417 71,417
Total Revenues 3,399,401 2,271,744 6,028,272 4,395,630
OPERATING EXPENSES        
Cost of product revenue (exclusive of amortization expense shown below) 4,334,019 1,344,241 5,950,306 2,610,662
Research and development 1,358,409 3,399,889 2,551,136 5,427,601
Plasma centers 1,600,170 1,294,301 3,079,646 2,574,720
Amortization of intangibles 73,021 0 73,021 0
Selling, general and administrative 4,435,650 1,724,163 8,713,034 3,432,033
TOTAL OPERATING EXPENSES 11,801,269 7,762,594 20,367,143 14,045,016
LOSS FROM OPERATIONS (8,401,868) (5,490,850) (14,338,871) (9,649,386)
OTHER INCOME (EXPENSE):        
Interest income 7,858 12,017 26,426 25,525
Interest expense (642,485) (537,998) (1,261,013) (1,005,439)
Other income 0 4,496 0 4,496
OTHER EXPENSE, NET (634,627) (521,485) (1,234,587) (975,418)
NET LOSS $ (9,036,495) $ (6,012,335) $ (15,573,458) $ (10,624,804)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.55) $ (0.50) $ (1.06) $ (0.93)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted 16,427,054 12,121,500 14,666,677 11,407,918

Source